Tasa de mortalidad de la mucormicosis orofacial relacionada con la Covid-19: Revisión sistemática
Resumen
La mucormicosis es una infección fúngica angioinvasiva cuya inoculación ocurre a través de la inhalación o el contacto directo con el organismo. Estos géneros de hongos tienen afinidad con pacientes con compromiso sistémico, como la diabetes y la hipertensión arterial. Produce zonas necróticas en la cavidad nasal, el paladar y en la región facial, no se hallaron revisiones sistemáticas actualizadas en español sobre la mortalidad de la mucormicosis asociada a la COVID-19 con manifestaciones orofaciales. Por ello, esta revisión describe la tasa de mortalidad de la mucormicosis en pacientes post-COVID-19. Se realizó una búsqueda de artículos científicos en fuentes de información electrónicas internacionales para identificar estudios publicados desde el 2021. Se encontró que la tasa mortalidad de mucormicosis orofacial asociada a COVID-19 oscila entre 12% y 50%. Entre los factores de riesgo de mortalidad están principalmente la diabetes mellitus y el uso de esteroides. Dada su letalidad, el despistaje de la infección micótica debe incluirse en la atención odontológica de los pacientes inmunosuprimidos con factores de riesgo. Las mucormicosis maxilofaciales suelen afectar la región facial, el paladar y los senos paranasales. También, se han notificado úlceras de mucormicosis en encía, labios, cresta alveolar, mejillas, lengua y mandíbula
RECIBO:08-11-25
ACEPTADO: 19-03-26
Palabras clave
Texto completo:
PDFReferencias
Janjua OS, Shaikh MS, Fareed MA, Qureshi SM, Khan MI, Hashem D, et al. Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes. Vol. 8, Journal of Fungi. 2022.
Mohammadi F, Badri M, Safari S, Hemmat N. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update. BMC Infect Dis [Internet]. 2021;21(1):1–7. https://doi.org/10.1186/s12879-021-06625-3
Dilek A, Ozaras R, Ozkaya S, Sunbul M, Itir E. COVID-19-associated mucormycosis: Case report and systematic review. Travel Med Infect Dis. 2021;44:102148.
Kumar A, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr Clin Res Rev. 2021;15:102146.
Zavaleta M, Espinoza J, Ávalos R, Alarorre S. Mucormicosis, reporte de un caso y revisión de la literatura. Med Interna Mex. 2019;42(3):55–61.
Ramphul K, Verma R, Kumar N, Ramphul Y, Mejias S, Lohana P. Rising concerns of mucormycosis (Zygomycosis) among covid-19 patients; an analysis and review based on case reports in literature. Acta Biomed. 2021;92(4).
Machado JA, Morales D, Armenta JS, Pérez ML, Cárdenas AZ. Mucormicosis rino-órbito-cerebral asociada con COVID- 19 y factores relacionados a la mortalidad. revisión sistemática. Rev ORL. 2025;16:1–21.
Song G, Liang G, Liu W. Fungal Co-infections Associated with Global COVID-19 Pandemic: A Clinical and Diagnostic Perspective from China. Mycopathologia [Internet]. 2020;185(4):599–606. https://doi.org/10.1007/s11046-020-00462-9
Hussain S, Riad A, Singh A, Klugarová J, Antony B, Banna H, et al. Global prevalence of COVID-19-associated mucormycosis (CAM): Living systematic review and meta-analysis. J Fungi. 2021;7(11):1–16.
Alonzo-Pico OM, Guerroro Morán P, Córdoba J, Guepud-Guapaz A. Mucormicosis en pacientes inmunodeprimidos por el uso de esteroides en pacientes covid-19. Rev Arbitr Interdiscip Ciencias la Salud SALUD Y VIDA. 2021;5(1):33–43.
Shah NN, Khan Z, Ahad H, Elderdery AY, Alomary MN, Atwah B, et al. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review. J Infect Public Health [Internet]. 2022;15(11):1299–314. https://doi.org/10.1016/j.jiph.2022.10.011
Gupta K, Singh A, Kalia A, Kandhola R. Anaesthetic considerations for post-COVID-19 mucormycosis surgery- A case report and review of literature. Indian J Anaesth. 2021;65(7):545–7.
Ansari S, Malik J, Fernandes A, Keluskar V, Charantimath S. COVID-19 associated rhinomaxillary mucormycosis: a case series and review of literature. Brazilian J Oral Sci. 2022;21:1–12.
Ahmed E, Abou-Bakr A, Hussein RR, El-Gawish AA, Ras A bakr E, Ghalwash DM. Oral mucormycosis in post-COVID-19 patients: A case series. Oral Dis. 2021;(July):1–2.
Ahmadikia K, Hashemi SJ, Khodavaisy S, Getso MI, Alijani N, Badali H, et al. The double-edged sword of systemic corticosteroid therapy in viral pneumonia: A case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis. Mycoses. 2021;64(8):798–808.
Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral Mucormycosis and COVID-19 Pneumonia. J Med Cases. 2021;12(3):85–9.
Maini A, Tomar G, Khanna D, Kini Y, Mehta H, Bhagyasree V. Sino-orbital mucormycosis in a COVID-19 patient: A case report. Int J Surg Case Rep [Internet]. 2021;82(April):105957. https://doi.org/10.1016/j.ijscr.2021.105957
Samaranayake LP, Fakhruddin KS, Ngo HC, Bandara HMNM, Leung YY. Orofacial Mycoses in Coronavirus Disease-2019 (COVID-19): A Systematic Review. Int Dent J [Internet]. 2022;72(5):607–20. https://doi.org/10.1016/j.identj.2022.02.010
Mehrabi Z, Salimi M, Niknam K, Mohammadi F, Mamaghani HJ, Sasani MR, et al. Sinoorbital Mucormycosis Associated with Corticosteroid Therapy in COVID-19 Infection. Case Rep Ophthalmol Med. 2021;2021(July 2020):1–7.
Elguera-Falcón F, Cumpa-Quiróz R. Mucormicosis en pacientes diabéticos post infección por COVID-19. Rev la Soc Peru Med Interna. 2020;33(4):176–82.
Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2022;32(4):NP11–6.
Tavakolpour S, Irani S, Yekaninejad MS, Alimardi M, Hasibi M, Abdollahi H, et al. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study. Mycopathologia [Internet]. 2022;5. https://doi.org/10.1007/s11046-022-00670-5
Venugopal A, Marya A. Palatal mucormycosis in a patient with SARSCoV-2 infection. JAMC. 2021;193(32):E1254.
Royero-León C, Sojo-Milano M, Pérez-Castro L, Barazarte-Sánchez D, Golaszewski J, Muñoz-Gelvez R, et al. Mucormicosis asociada a la COVID-19 en Venezuela: consideraciones en torno a un caso y revisión de la literatura. Invest Clin. 2023;64(2):206–25.
Escobar DF, Uribe JM, Riffo SM. Mucormicosis de cabeza y cuello?: Actualización en el diagnóstico y manejo médico-quirúrgico. Una revisión narrativa. Rev Asoc Odontol Argent 2023. 2023;111(3):1–7.
Pasternak M, Olszanecki R. Mucormycosis in head and neck area - the emerging health problem in COVID-19 pandemic. The perspective of a dental practitioner. Folia Med Cracov. 2021;61(2):117–27.
Özbek L, Topçu U, Manay M, Esen BH, Bektas SN, Aydin S, et al. COVID-19–associated mucormycosis: a systematic review and meta-analysis of 958 cases. Clin Microbiol Infect. 2023;29(6):722–31.
Khiabani K, Amirzade-Iranaq M, Ahmadi H. An Update on COVID-19 Associated Mucormycosis Characteristics, Risk Factors, and Outcomes: a Systematic Review and Meta-Analysis. Curr Fungal Infect Rep. 2023;17:282–295.
Owaysee H, Reza A. Mortality after Covid-19- related Mucormycosis in Critically ill Patients: A Systematic Review. EJCMPR. 2023;2(5):187–93.
Bhattacharyya, A, Sarma B, J. S. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Indian J Pharmacol. 2021;53:317–27.
Dolatabadi S, Bakhshaee M, Hosseinpoor M, Noghani AA, Afzalzadeh M, Roshanzamir I, et al. Mortality and Morbidity among COVID-19-Associated Mucormycosis Patients in Iran: A Prospective Cohort Study. Adv Infect Dis. 2023;13(03):407–23.
Afzal S, Nasir M. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review. J Coll Physicians Surg Pakistan. 2022;32(5):639–45.
Hoenigl M, Seidel D, Carvalho A, Rudramurthy SM, Arastehfar A, Gangneux JP, et al. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. The Lancet Microbe [Internet]. 2022;3(7):e543–52. http://dx.doi.org/10.1016/S2666-5247(21)00237-8
Sigera LSM, Denning DW. A Systematic Review of the Therapeutic Outcome of Mucormycosis. Open Forum Infect Dis [Internet]. 2024;11(1):1–9. https://doi.org/10.1093/ofid/ofad704
Jaritza LN, Anzules-Guerra B, Milian-Hernández J. Mucormicosis asociada a covid-19: revisión de la literatura. Rev Científica Arbitr en Investig la Salud ‘‘GESTAR”. 2022;5(10):22–39.
Pomarada ME, Ramirez LI, Rea AE, Morales SD, Cohen RI, Karaben VE. Mucormicosis asociada a COVID-19. Revisión de la literatura para odontólogos. Rev Asoc Odontol Argent. 2022;110(2):1–9.
Murugavel A, Raghunathan S, Ramakrishnan J. A Systematic Review and Global Meta-analysis of Secondary Fungal Infections Associated with COVID-19. MedRxiv. 2024;
Kamat M, Datar U, Byakodi S, Kamat S, Kumar VV. COVID-19-associated mucormycosis of head-and-neck region?: A systematic review. J Clin Transl Res. 2022;8(1):31–42.
Watanabe A, So M, Mitaka H, Ishisaka Y, Takagi H, Inokuchi R, et al. Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis. Mycopathologia [Internet]. 2022;187(2–3):271–89. https://doi.org/10.1007/s11046-022-00627-8
Ostovan VR, Tabrizi R, Bazrafshan H, Bahrami Z, Khazraei H, Khazraei S, et al. Mortality-Related Risk Factors for Coronavirus Disease (COVID-19)-Associated Mucormycosis: a systematic review and meta-analysis. Curr Fungal Infect Rep [Internet]. 2022;16(4):143–53. https://doi.org/10.1007/s12281-022-00440-2
Sáenz C, Solares P, Medina P, Argueta V, Orozco R. Mucormicosis rinocerebral en el Hospital General San Juan de Dios, Guatemala. Rev médica (Colegio Médicos y Cir Guatemala). 2021;160(2):144–7.
Deek AJ, Boukovalas S, Rathfoot CJ, Gotcher JE. Rhinocerebral Mucormycosis as a Sequelae of COVID-19 Treatment: A Case Report & Literature Review. J Oral Maxillofac Surg. 2022;80(2):333–40.
Mantilla-Hernandez JC, Villada-Murillo MF, Mendoza-Mogollón ET. Análisis patológico en un paciente inmunodeprimido con mucormicosis: presentación de caso. Rev Médicas UIS. 2024;37(1):87–93.
con COVID-19. Acta Médica Colomb. 2023;48(4):1–5.
López DC, Castañeda EGR, Arévalo CEC, Rivera JGC, Moctezuma AA. Mucormicosis rino-órbito-cerebral: casuística en un hospital de tercer nivel en México, en 3 años. Rev Esp Cir Oral y Maxilofac. 2022;44(1):23–9.
Frías-De-León MG, Pinto-Almazán R, Hernández-Castro R, García-Salazar E, Meza-Meneses P, Rodríguez-Cerdeira C, et al. Epidemiology of systemic mycoses in the covid-19 pandemic. J Fungi. 2021;7(7):1–26.
Ghasemi S, Dashti M, Fahimipour A, Daryakenari G, Mirzaei F, Akbari F, et al. Onset of Mucormycosis in Patients with COVID-19: A Systematic Review on Patients’ Characteristics. Eur J Dent. 2023;17(1):24–38.
Bhatt K, Agolli A, H. Patel M, Garimella R, Devi M, Garcia E, et al. High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections. Discoveries. 2021;9(1):e126.
Quintero Bauman A, Lugo Machado JA, Sainz Fuentes N, del Carmen Arellano Rodríguez I, Canche Martín EM, Reina Loaiza JR, et al. Factores de riesgo asociados con mortalidad en pacientes con mucormicosis rino-órbito-cerebral y COVID-19. Med Interna Mex. 2023;39(5):734–42.
Bhambhani D, Bhambhani G, Thomas S, Bhambhani S, Parlani S, Tandon R. Comparison Between Pre-COVID and Post-COVID Mucormycosis: A Systematic Review and Meta-analysis. J Maxillofac Oral Surg [Internet]. 2024;23(1):135–44. https://doi.org/10.1007/s12663-023-02028-w
Afzal S, Nasir M. Aspergillosis and Mucormycosis in COVID-19 Patients; a Systematic Review and Meta-analysis. MedRxiv. 2021;
Nagalli S, Kikkeri NS. Mucormycosis in COVID-19: A systematic review of literature. Infez Med. 2021;29(4):504–12.
Nambiar M, Varma SR, Jaber M, Sreelatha S V., Thomas B, Nair AS. Mycotic infections–mucormycosis and oral candidiasis associated with Covid-19: a significant and challenging association. J Oral Microbiol [Internet]. 2021;13(1). https://doi.org/10.1080/20002297.2021.1967699
Torres Hastahuamán CS. Conocimientos y actitudes sobre la COVID-19 en estudiantes de odontología de la Universidad Norbert Wiener en el 2020 [Internet]. Universidad Privada Norbert Wiener; 2020 [cited 2021 Aug 14]. http://repositorio.uwiener.edu.pe/handle/123456789/4294
Baños-Rodríguez TE, Hernández-López RA, Vidales-Santiago JA, Vela-Aguilar A, Reyes-M´éndez E, Mata-Villanueva FU, et al. Mucormicosis maxilar asociado a COVID-19, tratamiento médico-quirúrgico y manejo multidisciplinario. Reporte de caso. Rev Sanid Milit. 2023;77(3):1–8.
Velasco JC, Vargas LJ, García L, Torres IJ, González IC. Mucormicosis oral asociada a COVID-19 y diabetes mellitus: descripción de un caso. Biomédica. 2024;44(1):10–5.
Jiménez-Ruiz A, García-Grimshaw M, Ruiz-Sandoval JL. Neurologic manifestations of COVID-19. Gac Med Mex [Internet]. 2020 [cited 2021 Aug 20];156:258. www.gacetamedicademexico.com
Checchi V, Bellini P, Bencivenni D, Consolo U. COVID-19 dentistry-related aspects: a literature overview. Vol. 71, International Dental Journal. Wiley-Blackwell Publishing Ltd; 2020. p. 21–6.
Occidente HR De. Mucormicosis post-COVID-19. 2021;160(1):260–2.
Zhao D, Yu J, Zhang T, Du M, Yang Q, Li Z, et al. Impact of COVID-19 on advanced dental education: Perspectives of dental residents in Wuhan. J Dent Educ. 2021 Jun 1;85(6):756–67.
Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020 May 1;109:102433
Egido-Moreno S, Valls-Roca-Umbert J, Jané-Salas E, López-López J, Estrugo-Devesa A. COVID-19 and oral lesions, short communication and review. J Clin Exp Dent. 2021;13(3):e287–94.
Barazarte D, Golaszewski J, Moro L, Benaim D, León CR, Pérez L. Mucormycosis associated with COVID-19 patients: a first report in Venezuela. Lat Am J Oral Maxillofac Surg. 2022;2(3):128–33.
González Insfrán R, Tornaco R, Lezcano Machi A, Pérez Girala E, Mena Canata C. Rhino-Orbito-Cerebral Mucormycosis associated with COVID-19. Case report and literature review. Int J Med Surg Sci. 2023;10:1–7.
Jiménez PS, Meza MF, Azcona RM, Aguirre JG. Mucormicosis rino-orbitaria en un paciente con diabetes mellitus y arritmia . Reporte de caso clínico Rhino-orbitary mucormycosis in a patient with diabetes mellitus and arrhythmia . A case report. 2024;4(4):152–5.
Ibarra-González JO, González-Meléndez LA, Muñoz-Hernández G, Jorge Alberto JA, Sánchez-Santa Ana JR. Mucormicosis rino-orbito-cerebral: Reporte de caso y su abordaje en el Hospital Central Militar de México. Rev Sanid Milit. 2024;78(2):1–9.
Moher D, Shamseer L, Clarke M, Ghersi D, Liberatî A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev [Internet]. 2015;4(1):1–9.
Moher D, Liberati A, Tetzlaff J, Altman DG, Grp P. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Phys Ther. 2009;89(9):873–80.
da Costa Santos C, de Mattos Pimenta C, Cuce Nobre M. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Rev Lat Am Enfermagem [Internet]. 2007 [cited 2021 Mar 23];15(3):508–11. www.eerp.usp.br/rlae
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomized studies (MINORS): development and validation of a new instrument. ANZ J Surg [Internet]. 2003 Sep 1 [cited 2021 Feb 25];73(9):712–6. http://doi.wiley.com/10.1046/j.1445-2197.2003.02748.x
OHRI OHRI. Newcastle-Ottawa quality assessment scale form for cohort studies. 2014.
Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open [Internet]. 2016 [cited 2021 Sep 29];6:e011458. http://bmjopen.bmj.com/
Sharma A, Sharma A, Soubani AO. Epidemiology of COVID 19-Associated Mucormycosis in the United States. Chest. 2024;165(2):307–12.
Erami M, Raiesi O, Momen-Heravi M, Mirhendi H, Aboutalebian S, Getso MI, et al. COVID-19 associated mucormycosis (CAM) in Kashan, Iran: clinical presentations, risk factors, management, and outcomes. Infect Dis (Auckl) [Internet]. 2024;56(2):81–90. https://doi.org/10.1080/23744235.2023.2267669
Fouad YA, Bakre HM, Nassar MA, Gad MOA, Shaat AAK. Characteristics and Outcomes of a Series of COVID-Associated Mucormycosis Patients in Two Different Settings in Egypt Through the Third Pandemic Wave. Clin Ophthalmol. 2021;15:4795–800.
Dravid A, Kashiva R, Khan Z, Bande B, Memon D, Kodre A, et al. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India. Mycoses. 2022;65(5):526–40.
Nagarkar NM, Sahu V, Arora R, Pathak M, Shambharkar MS, Naveen P. Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India. Int Ophthalmol. 2023;43(7):2363–70.
Abdelsamie AM, Abdelazim HM, Elnems MG, Abdelhakam RB, Abdelalim AA. Covid-19-Related Acute Invasive Fungal Sinusitis: Clinical Features and Outcomes. Int Arch Otorhinolaryngol. 2022;26(1):E152–7.
Mina Fayez S, Magdy Sabry S, Salah M, Maher M. Risk factors affecting outcome of rhino-orbital-cerebral mucormycosis in COVID-19 patients. Egypt J Otolaryngol [Internet]. 2023;39(1). https://doi.org/10.1186/s43163-023-00406-2
Sharma R, Rana AK, Sharma VK, Tyagi A, Gupta S, Yadav V. Mucormycosis during COVID-19 Pandemic: A Cataclysmic Association. Clin Rhinol. 2024;15(3):3–9.
Patel P, Patel M, Shah K. A Study Of Risk Factors, Complications, Prognostic Factors And Outcome Of Covid Associated Mucormycosis In A Tertiary Care Hospital Of South Gujarat. Int J Med Sci Curr Res. 2025;8(1):151–9.
Janipour M, Shahriari A, Faramarzi A, Owji SH, Golshannia ME, Kherad M, et al. Comparative Mortality and Risk Analysis in Mucormycosis Cases: Pre-Pandemic Versus COVID-19 Association. Indian J Otolaryngol Head Neck Surg. 2025;77(8):3040–8.
Sahin M, Yilmaz M, Mert A, Naghili B, Ravanbakhsh F, Varshochi M, et al. mucormycosis: The international ID-IRI study. Med Mycol. 2024;62(7):1–9.
Choksi T, Agrawal A, Date P, Rathod D, Gharat A, Ingole A, et al. Cumulative Mortality and Factors Associated with Outcomes of Mucormycosis after COVID-19 at a Multispecialty Tertiary Care Center in India. JAMA Ophthalmol. 2022;140(1):66–72.
Yadav V, Bhagat S, Goel K, Sibia RS, Sharma DK, Sidhu T, et al. Outcomes of COVID-19-associated mucormycosis epidemic in India: A prospective 2-year follow-up study. World J Otorhinolaryngol - Head Neck Surg. 2025;11(1):66–73.
Gaurkar SS, Deshmukh PT, Khan FQ. Post COVID rhino-cerebral mucormycosis at a tertiary hospital in Central India: a retrospective cohort study. Egypt J Otolaryngol [Internet]. 2024;40(1). https://doi.org/10.1186/s43163-024-00707-0
Zia Z, Sajadi MJ, Bazrafshan H, Khademi B, Janipour M. Survival and prognostic factors in rhino-orbito-cerebral mucormycosis: A 3-year cohort study. Sci Rep. 2025;15(1):1–9.
Residente I, Cl H, Blesa UL, Mar A, Cl H, Blesa UL, et al. Mucormicosis rinocerebral. Una infección peligrosa 19. 2024;1–12.
Anand T, Mukherjee A, Satija A, Velamuri PS, Singh KJ, Das M, et al. A case control investigation of COVID-19 associated mucormycosis in India. BMC Infect Dis. 2022;22(1):1–12.
Balasopoulou A, ?okkinos P, Pagoulatos D, Plotas P, Makri OE, Georgakopoulos CD, et al. Outcomes of surgical management in orbital cellulitis due to mucormycosis in patients recovered from COVID-19. BMC Ophthalmol [Internet]. 2025;17(1):1.
Guerrero Y, Guerrero D. Manifestaciones orales relacionadas con la COVID-19. Int J Odontostomat [Internet]. 2021 [cited 2021 Sep 30];15(2):307–8. https://www.doi.org/10.1111/odi.13555
Portilla Robertson J, Reyes Castañeda E, Zeta Castañeda E, Santos Jaimes E, Alonso Moctezuma A. Mucormicosis rino-órbito-cerebral con manifestación palatina en un paciente diabético. A propósito de un caso clínico y revisión de la literatura. Rev Mex Cirugía Bucal y Maxilofac. 2020;16(2–3):91–6.
Martín Gómez MT, Salavert Lletí M. Mucormicosis: perspectiva de manejo actual y de futuro. Rev Iberoam Micol. 2021;38(2):91–100.
Virginia Reviglio M, Hausberger A, Osaba M, Nigatake Y, Inés González Castellanos M, Reviglio V. Mucormicosis rinoorbitaria en paciente diabético: a propósito de un caso. Oftalmol Clínica y Exp. 2024;17(1):105–9.
Zambrano C, Vera J, Napa V. Mucormicosis y post-COVID-19: sintomatología, diagnóstico y prevención a nivel mundial. Rev Científica Salud BIOSANA. 2025;5(2):148–60.
Benavente Garay F, González R, Daiub ME. Mucormicosis rino - órbito- cerebral pos- COVID. Rev Nac [Internet]. 2022;14(2):111–3.
Oliveira D. Mucormicosis rino-orbito-cerebral a propósito de un caso 1. 2024;40(1):64–9.
Lotto M, Strieder AP, Ayala Aguirre PE, Oliveira TM, Andrade Moreira Machado MA, Rios D, et al. Parental-oriented educational mobile messages to aid in the control of early childhood caries in low socioeconomic children: A randomized controlled trial. J Dent. 2020 Oct 1;101.
Sánchez Vargas KB, Ramírez Bustos A, Navarro Ocampo G. Mucormicosis rinocerebral e infeccion por SARS-CoV-2. Rev la Fac Med la UNAM [Internet]. 2021;32–42. http://doi.org/10.22201/fm.24484865e.2021.64.6.04
Todos los documentos publicados en esta revista se distribuyen bajo una
Licencia Creative Commons Atribución -No Comercial- Compartir Igual 4.0 Internacional.
Por lo que el envío, procesamiento y publicación de artículos en la revista es totalmente gratuito.